Please ensure Javascript is enabled for purposes of website accessibility

Why Teladoc Health Fell by 6.6% Today

By Eric Volkman - May 10, 2021 at 5:48PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A noted analyst's price target cut wasn't healthy for the stock.

What happened

Shares of Teladoc Health (TDOC 6.13%) were a bit sickly on Monday after one of the more prominent analysts tracking the stock knocked his target price down.

So what

Truist Securities' Sandy Draper, who has closely followed the fortunes of Teladoc throughout the coronavirus pandemic, was the prognosticator shaving his price target. He now believes the company is worth $206 per share, quite some distance down from his previous level of $275. However, Draper still recommends Teladoc as a buy.

Medical professional using a laptop with his stethoscope nearby.

Image source: Getty Images.

The change comes not long after Teladoc reported its first-quarter results. Fueled by the absorption of Livongo Health and a dramatic, coronavirus-era increase in demand for telehealth services (its specialty), the company enjoyed year-over-year revenue growth of 151%.

That was more or less expected by analysts, however, while the healthcare services provider's net loss was just shy of $200 million. That compared very unfavorably to only $29.6 million in the year-ago quarter and was significantly deeper than the average analyst forecast.

Now what

While investors can accept Teladoc's lack of upside surprise in revenue and even continued losses on the bottom line, other areas of the company's operations are concerning. For instance, on a quarter-over-quarter basis in Q1, its number of paid members -- a crucial metric for Teladoc -- actually slipped to 51.5 million from 51.8 million.

Besides, the investor trend these days is away from coronavirus stocks like Teladoc in favor of companies seemingly better poised to benefit from the recovery as the pandemic subsides.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Teladoc Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Teladoc Health, Inc. Stock Quote
Teladoc Health, Inc.
TDOC
$40.32 (6.13%) $2.33

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
389%
 
S&P 500 Returns
125%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/12/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.